Infliximab Injection

Generic name: Pronounced as (in flix' I mab)
Brand names
  • Avsola® (Infliximab-axxq)
  • Inflectra® (Infliximab-dyyb)
  • Remicade® (Infliximab)
  • Renflexis® (Infliximab-abda)
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 03/15/2021

Infliximab injection, infliximab-dyyb injection, and infliximab-abda injection are biologic medications (medications made from living organisms). Biosimilar infliximab-dyyb injection and infliximab-abda injection are highly similar to infliximab injection and work the same way as infliximab injection in the body. Therefore, the term infliximab injection products will be used to represent these medications in this discussion.

Infliximab injection products may decrease your ability to fight infection and increase the risk that you will get a serious infection, including severe viral, bacterial, or fungal infections that may spread throughout the body. These infections may need to be treated in a hospital and may cause death. Tell your doctor if you often get any type of infection or if you think you may have any type of infection now. This includes minor infections (such as open cuts or sores), infections that come and go (such as cold sores) and chronic infections that do not go away. Also tell your doctor if you have diabetes or any condition that affects your immune system and if you live or have ever lived in areas such as the Ohio or Mississippi river valleys where severe fungal infections are more common. Ask your doctor if you do not know if infections are more common in your area. Also tell your doctor if you are taking medications that decrease the activity of the immune system such as abatacept (Orencia); anakinra (Kineret); methotrexate (Otrexup, Rasuvo, Trexall, Xatmep); steroids such as dexamethasone, methylprednisolone (Medrol), prednisolone (Orapred ODT, Pediapred, Prelone), or prednisone; or tocilizumab (Actemra).

Your doctor will monitor you for signs of infection during and shortly after your treatment. If you have any of the following symptoms before you begin your treatment or if you experience any of the following symptoms during or shortly after your treatment, call your doctor immediately: weakness; sweating; difficulty breathing; sore throat; cough; coughing up bloody mucus; fever; extreme tiredness; flu-like symptoms; warm, red, or painful skin; diarrhea; stomach pain; or other signs of infection.

You may be infected with tuberculosis (TB, a severe lung infection) or hepatitis B (a virus that affects the liver) but not have any symptoms of the disease. In this case, infliximab injection products may increase the risk that your infection will become more serious and you will develop symptoms. Your doctor will perform a skin test to see if you have an inactive TB infection and may order a blood test to see if you have an inactive hepatitis B infection. If necessary, your doctor will give you medication to treat this infection before you start using an infliximab injection product. Tell your doctor if you have or have ever had TB, if you have lived in or visited a place where TB is common, or if you have been around someone who has TB. If you have any of the following symptoms of TB, or if you develop any of these symptoms during your treatment, call your doctor immediately: cough, weight loss, loss of muscle tone, fever, or night sweats. Also call your doctor immediately if you have any of these symptoms of hepatitis B or if you develop any of these symptoms during or after your treatment: excessive tiredness, yellowing of the skin or eyes, loss of appetite, nausea or vomiting, muscle aches, dark urine, clay-colored bowel movements, fever, chills, stomach pain, or rash.

Some children, teenagers, and young adults who received an infliximab injection product or similar medications developed severe or life-threatening cancers including lymphoma (cancer that begins in the cells that fight infection). Some teenage and young adult males who took an infliximab product or similar medications developed hepatosplenic T-cell lymphoma (HSTCL), a very serious form of cancer that often causes death within a short period of time. Most of the people who developed HSTCL were being treated for Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) or ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum) with an infliximab injection product or a similar medication along with another medication called azathioprine (Azasan, Imuran) or 6-mercaptopurine (Purinethol, Purixan). Tell your child's doctor if your child has ever had any type of cancer. If your child develops any of these symptoms during his treatment, call his doctor immediately: unexplained weight loss; swollen glands in the neck, underarms, or groin; or easy bruising or bleeding. Talk to your child's doctor about the risks of giving an infliximab injection product to your child.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with an infliximab injection product and each time you receive the medication. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs/DrugSafety/ucm085729.htm) or the manufacturer's website to obtain the Medication Guide.

Talk to your doctor about the risks of using an infliximab injection product.

Infliximab injection products are used to relieve the symptoms of certain autoimmune disorders (conditions in which the immune system attacks healthy parts of the body and causes pain, swelling, and damage) including:

  • rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) that is also being treated with methotrexate (Rheumatrex, Trexall),

  • Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) in adults and children 6 years of age or older that has not improved when treated with other medications,

  • ulcerative colitis (condition that causes swelling and sores in the lining of the large intestine) in adults and children 6 years of age or older that has not improved when treated with other medications,

  • ankylosing spondylitis (a condition in which the body attacks the joints of the spine and other areas causing pain and joint damage),

  • plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults when other treatments are less appropriate,

  • and psoriatic arthritis (a condition that causes joint pain and swelling and scales on the skin).

Infliximab injection products are in a class of medications called tumor necrosis factor-alpha (TNF-alpha) inhibitors. They work by blocking the action of TNF-alpha, a substance in the body that causes inflammation.

Infliximab injection products come as a powder to be mixed with sterile water and administered intravenously (into a vein) by a doctor or nurse. It is usually given in a doctor's office once every 2 to 8 weeks, more often in the beginning of your treatment and less often as your treatment continues. It will take about 2 hours for you to receive your entire dose of an infliximab, injection product.

Infliximab injection products may cause serious adverse reactions, including allergic reactions during an infusion and for 2 hours afterward. A doctor or nurse will monitor you during this time to be sure you are not having a serious reaction to the medication. You may be given other medications to treat or prevent reactions to an infliximab injection product. Tell your doctor or nurse immediately if you experience any of the following symptoms during or shortly after your infusion: hives; rash; itching; swelling of the face, eyes, mouth, throat, tongue, lips, hands, feet, ankles, or lower legs; difficulty breathing or swallowing; flushing; dizziness; fainting; fever; chills; seizures; vision loss; and chest pain.

Infliximab injection products may help control your symptoms, but they will not cure your condition. Your doctor will watch you carefully to see how well infliximab injection products work for you. If you have rheumatoid arthritis or Crohn's disease, your doctor may increase the amount of medication you receive, if needed. If you have Crohn's disease and your condition has not improved after 14 weeks, your doctor may stop treating you with an infliximab injection product. It is important to tell your doctor how you are feeling during your treatment.

Infliximab injection products are also sometimes used to treat Behcet's syndrome (ulcers in the mouth and on the genitals and inflammation of various parts of the body). Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before using an infliximab injection product,

  • tell your doctor and pharmacist if you are allergic to infliximab, infliximab-axxq, infliximab-dyyb, infliximab-abda, any medications made from murine (mouse) proteins, any other medications, or any of the ingredients in infliximab, infliximab-dyyb, or infliximab-abda injection. Ask your doctor or pharmacist if you don't know whether a medication you are allergic to is made from murine proteins. Ask your pharmacist or check the Medication Guide for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: anticoagulants (blood thinners) such as warfarin (Coumadin), cyclosporine (Gengraf, Neoral, Sandimmune), and theophylline (Elixophyllin, Theo-24, Theochron). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had heart failure (condition in which the heart cannot pump enough blood to other parts of the body). Your doctor may tell you not to use an infliximab injection product.

  • tell your doctor if you have ever been treated with phototherapy (a treatment for psoriasis that involves exposing the skin to ultraviolet light) and if you have or have ever had a disease that affects your nervous system, such as multiple sclerosis (MS; loss of coordination, weakness, and numbness due to nerve damage), Guillain-Barre syndrome (weakness, tingling, and possible paralysis due to sudden nerve damage) or optic neuritis (inflammation of the nerve that sends messages from the eye to the brain); numbness, burning or tingling in any part of your body; seizures; chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways); any type of cancer; bleeding problems or diseases that affect your blood; or heart disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while using an infliximab injection product, call your doctor. If you use an infliximab injection product during your pregnancy, be sure to talk to your baby's doctor about this after your baby is born. Your baby may need to receive certain vaccinations later than usual.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are using an infliximab injection product.

  • tell your doctor if you have recently received a vaccine. Also check with your doctor to see if you need to receive any vaccinations. Do not have any vaccinations without talking to your doctor. It is important that adults and children receive all age-appropriate vaccines before beginning treatment with infliximab.

  • you should know that you may have a delayed allergic reaction 3 to 12 days after you receive an infliximab injection product. Tell your doctor if you experience any of the following symptoms several days or longer after your treatment: muscle or joint pain; fever; rash; hives; itching; swelling of the hands, face, or lips; difficulty swallowing; sore throat; and headache.

Unless your doctor tells you otherwise, continue your normal diet.

  • Infliximab injection products may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • nausea

    • heartburn

    • headache

    • runny nose

    • white patches in the mouth

    • vaginal itching, burning, and pain, or other signs of a yeast infection

    • flushing

  • Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, or those listed in the IMPORTANT WARNING or the SPECIAL PRECAUTIONS sections, call your doctor immediately:

    • any type of rash, including a rash on the cheeks or arms that gets worse in the sun

    • chest pain

    • irregular heartbeat

    • pain in the arms, back, neck, or jaw

    • stomach pain

    • swelling of the feet, ankles, stomach, or lower legs

    • sudden weight gain

    • shortness of breath

    • blurred vision or vision changes

    • sudden weakness of an arm or leg (especially on one side of the body) or of the face

    • muscle or joint pain

    • numbness or tingling in any part of the body

    • sudden confusion, trouble speaking, or trouble understanding

    • sudden trouble walking

    • dizziness or faintness

    • loss of balance or coordination

    • sudden, severe headache

    • seizures

    • yellowing of the skin or eyes

    • dark colored urine

    • loss of appetite

    • pain in the upper right part of the stomach

    • unusual bruising or bleeding

    • blood in stool

    • pale skin

    • red, scaly patches or pus-filled bumps on the skin

  • Infliximab injection may increase your risk of developing lymphoma (cancer that begins in the cells that fight infection) and other cancers.Talk to your doctor about the risks of receiving an infliximab injection product.

  • Infliximab injection products may cause other side effects. Call your doctor if you have any unusual problems while using this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Your doctor will store the medication in his or her office.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your doctor may order certain laboratory tests to check your body's response to an infliximab injection product.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

  • Anti-TNF-alpha
  • Anti-tumor Necrosis Factor-alpha
  • cA2

Drug Interaction
Penbutolol Penbutolol The metabolism of Acebutolol can be increased when combined with Infliximab.
Triamcinolone Triamcinolone The metabolism of Triamcinolone can be increased when combined with Infliximab.
Zolmitriptan Zolmitriptan The metabolism of Zolmitriptan can be increased when combined with Infliximab.
Pamidronate Injection Pamidronate Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Pamidronic acid.
Zidovudine Injection Zidovudine Injection The metabolism of Zidovudine can be increased when combined with Infliximab.
Trimipramine Trimipramine The metabolism of Trimipramine can be increased when combined with Infliximab.
Tenofovir Tenofovir The metabolism of Tenofovir can be increased when combined with Infliximab.
Tegaserod Tegaserod The metabolism of Tegaserod can be increased when combined with Infliximab.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be increased when combined with Infliximab.
Voriconazole Voriconazole The metabolism of Voriconazole can be increased when combined with Infliximab.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Infliximab.
Ibandronate Ibandronate The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Ibandronate.
Darifenacin Darifenacin The metabolism of Darifenacin can be increased when combined with Infliximab.
Rasagiline Rasagiline The metabolism of Rasagiline can be increased when combined with Infliximab.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Infliximab.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Rituximab.
Dronabinol Dronabinol The metabolism of Dronabinol can be increased when combined with Infliximab.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Azacitidine.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Decitabine.
Tretinoin Tretinoin The metabolism of Tretinoin can be increased when combined with Infliximab.
Bendamustine Injection Bendamustine Injection The metabolism of Bendamustine can be increased when combined with Infliximab.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Infliximab is combined with Alemtuzumab.
Betaxolol Betaxolol The metabolism of Betaxolol can be increased when combined with Infliximab.
Everolimus Everolimus The metabolism of Everolimus can be increased when combined with Infliximab.
Fingolimod Fingolimod Infliximab may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Eribulin.
Acetaminophen Injection Acetaminophen Injection The metabolism of Acetaminophen can be increased when combined with Infliximab.
Vilazodone Vilazodone The metabolism of Vilazodone can be increased when combined with Infliximab.
Ipilimumab Injection Ipilimumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Ipilimumab.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Belimumab.
Roflumilast Roflumilast Infliximab may increase the immunosuppressive activities of Roflumilast.
Linagliptin Linagliptin The metabolism of Linagliptin can be increased when combined with Infliximab.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Infliximab.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be increased when combined with Infliximab.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Infliximab.
Vandetanib Vandetanib The metabolism of Vandetanib can be increased when combined with Infliximab.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be increased when combined with Infliximab.
Vismodegib Vismodegib The metabolism of Vismodegib can be increased when combined with Infliximab.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be increased when combined with Infliximab.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Infliximab.
Crizotinib Crizotinib The metabolism of Crizotinib can be increased when combined with Infliximab.
Pertuzumab Injection Pertuzumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Pertuzumab.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Carfilzomib.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Infliximab.
Mirabegron Mirabegron The metabolism of Mirabegron can be increased when combined with Infliximab.
Regorafenib Regorafenib The metabolism of Regorafenib can be increased when combined with Infliximab.
Bosutinib Bosutinib The metabolism of Bosutinib can be increased when combined with Infliximab.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Infliximab is combined with Teriflunomide.
Cabozantinib (thyroid cancer) Cabozantinib (thyroid cancer) The metabolism of Cabozantinib can be increased when combined with Infliximab.
Tofacitinib Tofacitinib The risk or severity of adverse effects can be increased when Infliximab is combined with Tofacitinib.
Alogliptin Alogliptin The metabolism of Alogliptin can be increased when combined with Infliximab.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Infliximab is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Ponatinib can be increased when combined with Infliximab.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Infliximab.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be increased when combined with Infliximab.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Infliximab.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be increased when combined with Infliximab.
Ospemifene Ospemifene The metabolism of Ospemifene can be increased when combined with Infliximab.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Infliximab.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be increased when combined with Infliximab.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Infliximab.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be increased when combined with Infliximab.
Lomitapide Lomitapide The metabolism of Lomitapide can be increased when combined with Infliximab.
Dapagliflozin Dapagliflozin The metabolism of Dapagliflozin can be increased when combined with Infliximab.
Apremilast Apremilast The therapeutic efficacy of Apremilast can be decreased when used in combination with Infliximab.
Ramucirumab Injection Ramucirumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Ramucirumab.
Ceritinib Ceritinib The metabolism of Ceritinib can be increased when combined with Infliximab.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Siltuximab.
Vedolizumab Injection Vedolizumab Injection The risk or severity of infection can be increased when Infliximab is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Infliximab.
Testosterone Injection Testosterone Injection The metabolism of Testosterone can be increased when combined with Infliximab.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be increased when combined with Infliximab.
Suvorexant Suvorexant The metabolism of Suvorexant can be increased when combined with Infliximab.
Dulaglutide Injection Dulaglutide Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Pembrolizumab.
Nivolumab Injection Nivolumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Nivolumab.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be increased when combined with Infliximab.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be increased when combined with Infliximab.
Riociguat Riociguat The metabolism of Riociguat can be increased when combined with Infliximab.
Pirfenidone Pirfenidone The metabolism of Pirfenidone can be increased when combined with Infliximab.
Nintedanib Nintedanib The metabolism of Nintedanib can be increased when combined with Infliximab.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Secukinumab.
Palbociclib Palbociclib The metabolism of Palbociclib can be increased when combined with Infliximab.
Panobinostat Panobinostat The metabolism of Panobinostat can be increased when combined with Infliximab.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Dinutuximab.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Infliximab.
Alirocumab Injection Alirocumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Alirocumab.
Evolocumab Injection Evolocumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Evolocumab.
Daclatasvir Daclatasvir The metabolism of Daclatasvir can be increased when combined with Infliximab.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be increased when combined with Infliximab.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be increased when combined with Infliximab.
Cariprazine Cariprazine The metabolism of Cariprazine can be increased when combined with Infliximab.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be increased when combined with Infliximab.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Infliximab.
Elotuzumab Injection Elotuzumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Elotuzumab.
Daratumumab Injection Daratumumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Daratumumab.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Infliximab.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Infliximab.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Infliximab.
Necitumumab Injection Necitumumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Necitumumab.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Infliximab.
Reslizumab Injection Reslizumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Reslizumab.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection The metabolism of Brivaracetam can be increased when combined with Infliximab.
Venetoclax Venetoclax The metabolism of Venetoclax can be increased when combined with Infliximab.
Cobicistat Cobicistat The metabolism of Cobicistat can be increased when combined with Infliximab.
Selexipag Selexipag The metabolism of Selexipag can be increased when combined with Infliximab.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Infliximab.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Infliximab.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be increased when combined with Infliximab.
Eliglustat Eliglustat The metabolism of Eliglustat can be increased when combined with Infliximab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be increased when combined with Infliximab.
Theophylline Theophylline The metabolism of Theophylline can be increased when combined with Infliximab.
Trazodone Trazodone The metabolism of Trazodone can be increased when combined with Infliximab.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Infliximab is combined with Tioguanine.
Thioridazine Thioridazine The metabolism of Thioridazine can be increased when combined with Infliximab.
Trifluoperazine Trifluoperazine The metabolism of Trifluoperazine can be increased when combined with Infliximab.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Infliximab is combined with Bleomycin.
Sulfadiazine Sulfadiazine The metabolism of Sulfadiazine can be increased when combined with Infliximab.
Benztropine Benztropine The metabolism of Benzatropine can be increased when combined with Infliximab.
Azathioprine Azathioprine The metabolism of Azathioprine can be increased when combined with Infliximab.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Infliximab.
Triamterene Triamterene The metabolism of Triamterene can be increased when combined with Infliximab.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be increased when combined with Infliximab.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Infliximab.
Tolbutamide Tolbutamide The metabolism of Tolbutamide can be increased when combined with Infliximab.
Tolazamide Tolazamide The metabolism of Tolazamide can be increased when combined with Infliximab.
Baclofen Baclofen The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Infliximab is combined with Baclofen.
Brompheniramine Brompheniramine The metabolism of Brompheniramine can be increased when combined with Infliximab.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Infliximab is combined with Mercaptopurine.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be increased when combined with Infliximab.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be increased when combined with Infliximab.
Vinblastine Vinblastine The metabolism of Vinblastine can be increased when combined with Infliximab.
Thiothixene Thiothixene The metabolism of Thiothixene can be increased when combined with Infliximab.
Aspirin Aspirin The metabolism of Acetylsalicylic acid can be increased when combined with Infliximab.
Triazolam Triazolam The metabolism of Triazolam can be increased when combined with Infliximab.
Trimethoprim Trimethoprim The metabolism of Trimethoprim can be increased when combined with Infliximab.
Timolol Timolol The metabolism of Timolol can be increased when combined with Infliximab.
Verapamil Verapamil The metabolism of Verapamil can be increased when combined with Infliximab.
Atenolol Atenolol The metabolism of Atenolol can be increased when combined with Infliximab.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Infliximab is combined with Streptozocin.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be increased when combined with Infliximab.
Tramadol Tramadol The metabolism of Tramadol can be increased when combined with Infliximab.
Lansoprazole Lansoprazole The metabolism of Lansoprazole can be increased when combined with Infliximab.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be increased when combined with Infliximab.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Gemcitabine.
Indinavir Indinavir The metabolism of Indinavir can be increased when combined with Infliximab.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be increased when combined with Infliximab.
Mirtazapine Mirtazapine The metabolism of Mirtazapine can be increased when combined with Infliximab.
Donepezil Donepezil The metabolism of Donepezil can be increased when combined with Infliximab.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Infliximab.
Celecoxib Celecoxib The metabolism of Celecoxib can be increased when combined with Infliximab.
Tolterodine Tolterodine The metabolism of Tolterodine can be increased when combined with Infliximab.
Thalidomide Thalidomide The metabolism of Thalidomide can be increased when combined with Infliximab.
Rabeprazole Rabeprazole The metabolism of Rabeprazole can be increased when combined with Infliximab.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists